A federal court in New York delivered a setback to the Food and Drug Administration, ruling the agency can’t bar a drug company from marketing a pill for off-label use as long as the claims are truthful.
from WSJ.com: US Business http://ift.tt/1MfSlYn
via IFTTT
No comments:
Post a Comment